RxDoctor Payments Data

Craig Schultz

Nurse Practitioner · Portland, ORNPI 1619911559

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 271 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 40.2% of the total. Among nurse practitioner clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,611in general payments, 2019–2025

Across 271 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$819
  • Lilly USA, LLC$499
  • Pfizer$459
  • E.r. Squibb & Sons, L.L.C.$388
  • Sanofi$360
  • plus $831 from 15 others

What the payments were for

  • Food & beverage$5,41797%
  • Education$1943%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,611 in reported general payments places this provider in the 95th percentile of 997 nurse practitioner providers in Oregon.

See all nurse practitioner providers in Oregon

Medicare billing

Part B allowed, 2024
$100,739
Medicare patients
343
Services billed
1,591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa19$401,731
Enbrel SureclickEtanercept20$185,599
Humira(Cf) PenAdalimumab16$105,037
Dupixent SyringeDupilumab11$39,298
Tacrolimus43$6,383
Fluorouracil48$3,121
Ketoconazole105$2,731
Clobetasol Propionate62$2,213
Sulfacetamide Sodium20$2,170
Calcipotriene14$1,331
Triamcinolone Acetonide116$1,293
Doxycycline Monohydrate41$1,051
Fluocinonide33$1,034
Metronidazole11$793
ValacyclovirValacyclovir Hcl13$679

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →